Greenwich Biosciences

GW Pharmaceuticals' Subsidiary Studies Nabiximols to Treat Multiple Sclerosis Related Spasticity

Greenwich Biosciences will be presenting its analysis regarding Nabiximol treatment at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly.Gre...